These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 8317232)

  • 1. [Nosocomial infections. Some aspects].
    Monteiro JA
    Acta Med Port; 1993; 6(3-4):135-40. PubMed ID: 8317232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multihospital surveillance of nosocomial methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and Clostridium difficile: analysis of a 4-year data-sharing project, 1999-2002.
    Burger T; Fry D; Fusco R; Luschini M; Mayo JB; Ng V; Roye-Horn K; Wagner N
    Am J Infect Control; 2006 Sep; 34(7):458-64. PubMed ID: 16945694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nosocomial infections--ecological niches].
    Dalgaard LS
    Ugeskr Laeger; 2009 Oct; 171(44):3172-4. PubMed ID: 19857394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Historical and changing epidemiology of healthcare-associated infections.
    Pearson A
    J Hosp Infect; 2009 Dec; 73(4):296-304. PubMed ID: 19925942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of methicillin-resistant Staphylococcus aureus.
    Boucher HW; Corey GR
    Clin Infect Dis; 2008 Jun; 46 Suppl 5():S344-9. PubMed ID: 18462089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clostridium difficile and fluoroquinolones: is there a link?
    Weiss K
    Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth and geographic variation in hospitalizations with resistant infections, United States, 2000-2005.
    Zilberberg MD; Shorr AF; Kollef MH
    Emerg Infect Dis; 2008 Nov; 14(11):1756-8. PubMed ID: 18976563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Collateral damage. The rise of resistant C. difficile.
    Taubes G
    Science; 2008 Jul; 321(5887):360. PubMed ID: 18635789
    [No Abstract]   [Full Text] [Related]  

  • 9. Prevalence of enterotoxin producing Staphylococcus aureus in stools of patients with nosocomial diarrhea.
    Flemming K; Ackermann G
    Infection; 2007 Oct; 35(5):356-8. PubMed ID: 17721737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications of the changing face of Clostridium difficile disease for health care practitioners.
    McFarland LV; Beneda HW; Clarridge JE; Raugi GJ
    Am J Infect Control; 2007 May; 35(4):237-53. PubMed ID: 17482995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methicillin-resistant Staphylococcus aureus nosocomial infections in ICU: risk factors, morbidity and cost].
    Lepelletier D; Ferréol S; Villers D; Richet H
    Pathol Biol (Paris); 2004 Oct; 52(8):474-9. PubMed ID: 15465267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiology of Clostridium difficile infection].
    Szczesny A; Martirosian G
    Przegl Epidemiol; 2002; 56(1):49-56. PubMed ID: 12150067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What has made the difference?
    Elston T
    J Hosp Infect; 2010 Jun; 75(2):136; author reply 136-7. PubMed ID: 20381899
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk factors for methicillin resistant and sensitive Staphylococcus aureus infection in a Brazilian university hospital.
    Sadoyama G; Gontijo Filho PP
    Braz J Infect Dis; 2000 Jun; 4(3):135-43. PubMed ID: 10934497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two time-series analyses of the impact of antibiotic consumption and alcohol-based hand disinfection on the incidences of nosocomial methicillin-resistant Staphylococcus aureus infection and Clostridium difficile infection.
    Kaier K; Hagist C; Frank U; Conrad A; Meyer E
    Infect Control Hosp Epidemiol; 2009 Apr; 30(4):346-53. PubMed ID: 19236282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surveillance for methicillin-resistant Staphylococcus aureus in Canadian hospitals--a report update from the Canadian Nosocomial Infection Surveillance Program.
    Can Commun Dis Rep; 2005 Feb; 31(3):33-40. PubMed ID: 15693179
    [No Abstract]   [Full Text] [Related]  

  • 17. Modelling the impact of antibiotic use and infection control practices on the incidence of hospital-acquired methicillin-resistant Staphylococcus aureus: a time-series analysis.
    Aldeyab MA; Monnet DL; López-Lozano JM; Hughes CM; Scott MG; Kearney MP; Magee FA; McElnay JC
    J Antimicrob Chemother; 2008 Sep; 62(3):593-600. PubMed ID: 18467307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare-associated infection in acute hospitals: which interventions are effective?
    Mears A; White A; Cookson B; Devine M; Sedgwick J; Phillips E; Jenkinson H; Bardsley M
    J Hosp Infect; 2009 Apr; 71(4):307-13. PubMed ID: 19201050
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of healthcare-associated methicillin-resistant Staphylococcus aureus.
    Hsu LY; Wijaya L; Tan BH
    Expert Rev Anti Infect Ther; 2005 Dec; 3(6):893-905. PubMed ID: 16307502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nosocomial antibiotic-associated diarrhea associated with enterotoxin-producing strains of methicillin-resistant Staphylococcus aureus.
    Boyce JM; Havill NL
    Am J Gastroenterol; 2005 Aug; 100(8):1828-34. PubMed ID: 16086721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.